Allervax Ragweed peptide immunotherapy: Began Phase II trials in 150 allergic patients, using nasal, conjunctival, and bronchial challenge. The bronchial challe

ImmuLogic Pharmaceutical Corp. (IMUL), Waltham,

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.